April 11, 2010 – FDA is alerting healthcare professionals that Sibutramine [Meridia] is contraindicated in patients with a history of cardiovascular disease because the drug increases their risk of heart attack and stroke. Sibutramine [Meridia] is used to manage obesity. …

Cardiovascular Risk with Sibutramine [Meridia] in Patients with a History of Cardiovascular Disease Read more »